+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Dual integrin and gastrin-releasing peptide receptor targeted tumor imaging using 18F-labeled PEGylated RGD-bombesin heterodimer 18F-FB-PEG3-Glu-RGD-BBN



Dual integrin and gastrin-releasing peptide receptor targeted tumor imaging using 18F-labeled PEGylated RGD-bombesin heterodimer 18F-FB-PEG3-Glu-RGD-BBN



Journal of Medicinal Chemistry 52(2): 425-432



Radiolabeled RGD and bombesin peptides have been extensively investigated for tumor integrin alpha(v)beta(3) and GRPR imaging, respectively. Due to the fact that many tumors are both integrin and GRPR positive, we designed and synthesized a heterodimeric peptide Glu-RGD-BBN, which is expected to be advantageous over the monomeric peptides for dual-receptor targeting. A PEG(3) spacer was attached to the glutamate alpha-amino group of Glu-RGD-BBN to enhance the (18)F labeling yield and to improve the in vivo kinetics. PEG(3)-Glu-RGD-BBN possesses the comparable GRPR and integrin alpha(v)beta(3) receptor-binding affinities as the corresponding monomers, respectively. The dual-receptor targeting properties of (18)F-FB-PEG(3)-Glu-RGD-BBN were observed in PC-3 tumor model. (18)F-FB-PEG(3)-Glu-RGD-BBN with high tumor contrast and favorable pharmacokinetics is a promising PET tracer for dual integrin and GRPR positive tumor imaging. This heterodimer strategy may also be an applicable method to develop other molecules with improved in vitro and in vivo characterizations for tumor diagnosis and therapy.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052726134

Download citation: RISBibTeXText

PMID: 19113865

DOI: 10.1021/jm801285t


Related references

MicroPET imaging of a gastrin-releasing peptide receptor-positive tumor in a mouse model of human prostate cancer using a 64Cu-labeled bombesin analogue. Bioconjugate Chemistry 14(4): 756-763, July-August, 2003

Preclinical pharmacokinetic, biodistribution, imaging and therapeutic efficacy of (177)Lu-Labeled glycated bombesin analogue for gastrin-releasing peptide receptor-positive prostate tumor targeting. Nuclear Medicine and Biology 42(3): 234-241, 2015

Evaluation of three different families of bombesin receptor radioantagonists for targeted imaging and therapy of gastrin releasing peptide receptor (GRP-R) positive tumors. Journal of Medicinal Chemistry 58(2): 682-691, 2015

Imaging adenoviral-mediated gene transfer of gastrin releasing peptide receptor using a Tc-99m-labeled bombesin analogue. Journal of Nuclear Medicine 39(5 Suppl. ): 224P-225P, 1998

Synthesis of (68)Ga-labeled NOTA-RGD-GE11 heterodimeric peptide for dual integrin and epidermal growth factor receptor-targeted tumor imaging. Journal of Labelled Compounds and Radiopharmaceuticals 58(7): 299-303, 2015

Evaluation of a 64Cu-labeled bombesin analogue for diagnosis of gastrin-releasing peptide receptor positive tumors by microPET imaging. Journal of Labelled Compounds & Radiopharmaceuticals 44(Suppl. 1): S81-S83, 2001

In vitro and in vivo evaluation of a 99mTc(I)-labeled bombesin analogue for imaging of gastrin releasing peptide receptor-positive tumors. Nuclear Medicine and Biology 29(5): 553-560, 2002

(68)Ga-labeled NOTA-RGD-BBN peptide for dual integrin and GRPR-targeted tumor imaging. European Journal of Nuclear Medicine and Molecular Imaging 36(9): 1483-1494, 2009

Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer. Nuclear Medicine and Biology 40(8): 1025-1034, 2013

(18) F labeled RGD-A7R peptide for dual integrin and VEGF-targeted tumor imaging in mice bearing U87MG tumors. Journal of Labelled Compounds and Radiopharmaceuticals 57(11): 627-631, 2014

PET of tumors expressing gastrin-releasing peptide receptor with an 18F-labeled bombesin analog. Journal of Nuclear Medicine 53(6): 947-952, 2012

Bombesin analogues for gastrin-releasing peptide receptor imaging. Nuclear Medicine and Biology 39(4): 461-471, 2012

Characterization of high-affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC-3 and DU-145: Internalization of receptor bound 125I-(Tyr-4) bombesin by tumor cells. Prostate 25(1): 29-38, 1994

Bombesin/oligoarginine fusion peptides for gastrin releasing peptide receptor (GRPR) targeted gene delivery. Bioorganic and Medicinal Chemistry 26(2): 516-526, 2018

Targeted imaging of gastrin-releasing peptide receptors with 99mTc-EDDA/HYNIC-[Lys3]-bombesin: biokinetics and dosimetry in women. Nuclear Medicine Communications 29(8): 741-747, 2008